$0.894700
-0.09-8.70%
At close: -
$0.931000
0.044.06%
After Hours: Nov 22, 8:46 AM EDT
Comments
Loading...
Barinthus Biotherapeutics (NASDAQ:BRNS) Stock, Earnings Estimates, EPS, And Revenue
Barinthus Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 6
EPS
$-0.210
Quarterly Revenue
$15M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$15M
Analyze the earnings history of Barinthus Biotherapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Barinthus Biotherapeutics (BRNS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-06 | $-0.21 | $-0.44 | 52.3 % |
| Jun 2024 | 2024-08-08 | $-0.43 | $-0.41 | -4.88 % |
| Mar 2024 | 2024-05-13 | $-0.40 | $-0.54 | 25.9 % |
| Dec 2023 | 2024-03-20 | $-0.45 | $-0.50 | 10.0 % |
Barinthus Biotherapeutics (BRNS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-13 | $0 | $130.00K | -100.0 % |
| Dec 2023 | 2024-03-20 | $0 | $130.00K | -100.0 % |
| Jun 2023 | 2023-08-10 | $334.00K | $600.00K | -44.3 % |
| Mar 2023 | 2023-05-12 | $468.00K | $1.50M | -68.8 % |
FAQ
When is Barinthus Biotherapeutics (NASDAQ:BRNS) reporting earnings?
Barinthus Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for Barinthus Biotherapeutics (NASDAQ:BRNS)?
Barinthus Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.21, which beat the estimate of $-0.44.
What were Barinthus Biotherapeutics’s (NASDAQ:BRNS) revenues?
Barinthus Biotherapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.